Preanalytics: Serum must be centrifuged and pipetted directly; 2-8°C 2 weeks
Indication:
Differentiation of an increased alkaline phosphatase with obscure disease This laboratory test is not analyzed alone but only in combination with a request for a profile Alkaline-Phosphatase Isoenzymes
Lab tests catalogue
Alkaline phosphatase
Accounting rules of the CNS: not to be cumulated with 5-Nukleotidase
Material: Serum
Method: Color test using a standardized method
Daily
Accredited:
Preanalytics: 7 days at 15-25 ° C 7 days at 2-8 ° C 2 months at (-20) ° C - (-25) ° C
Indication:
Monitoring of patients with Crohn`s disease or colitis ulcerosa. Enteral protein loss of other origin : Whipple's disease, necrotizing enterocolitis, intestinal tuberculosis, celiac disease, intestinal lymphoma and systemic lupus erythematodus
Preanalytics: 7 days at 2-8°C 3 months at -20°C Patients receiving high doses of biotin (> 5 mg / day) should be sampled at least 8 hours after the last application, as high levels of biotin may interfere with the test system.
Indication:
This analysis is only performed as part of a request for the fatty acid profile.
Lab tests catalogue
alpha-linolenic acid 18:3,n-3 (DBS)
Material: Dry blood
Method: GCMS
Once per week
Preanalytics: 3 days at 15-25°C
Indication:
Diagnostic of metabolic disorders This laboratory test will be performed only as part of a profile (fatty acid profile erythrocytes / DBS)
Lab tests catalogue
Alprazolam
Material: Urine
Method: LC-MS
2 times per week
Accredited:
Preanalytics: 5 days at 2-8 °C > 5 days at (-15) - (-25) °C
Indication:
This analysis can only be requested in the context of the collective analysis "Benzodiazepines" or the complete profile "Drugs of abuse & narcotics screening".
Lab tests catalogue
Aluminium
Accounting rules of the CNS: max 5 analyzes from the category of metals
Material: Trace element K2 EDTA (Plasma)
Method: AAS
Once per week
External service: *
Preanalytics: 7 days at 2 - 8 ° C
Indication:
Monitoring of aluminium-exposed patients (worker in aluminium manufacturing companies), monitoring of dialyzed patients taking aluminous antacids